Impact of Sepsis Mandates on Sepsis Care: Unintended Consequences.

The Journal of Infectious Diseases
Kai E Swenson, Dean L Winslow

Abstract

The creation of dedicated sepsis guidelines and their broad dissemination over the past 2 decades have contributed to significant improvements in sepsis care. These successes have spurred the creation of bundled care mandates by major healthcare payers, such as the Center for Medicare and Medicaid Services. However, despite the likely benefits of guideline-directed sepsis bundles, mandated treatments in sepsis may lead to unintended consequences as the standard of care in sepsis improves. In particular, the heterogeneous spectrum of presentation and disease severity in sepsis, as well as the complexity surrounding the benefits of specific interventions in sepsis, argues for an individualized and titrated approach to interventions: an approach generally not afforded by care mandates. In this review, we review the risks and benefits of mandated care for sepsis, with particular emphasis on the potential adverse consequences of common bundle components such as early empiric antibiotics, weight-based fluid administration, and serum lactate monitoring. Unlike guideline-directed care, mandated care in sepsis precludes providers from tailoring treatments to heterogeneous clinical scenarios and may lead to unintended harms for individua...Continue Reading

References

Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Aug 3, 2004·Critical Care Medicine·H Bryant NguyenMichael C Tomlanovich
Feb 27, 2008·Archives of Internal Medicine·James A WelkerJack D McCue
Jan 13, 2009·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Bret A NicksMichael T Fitch
May 14, 2010·American Journal of Respiratory and Critical Care Medicine·Tim C JansenUNKNOWN LACTATE study group
Jan 25, 2011·The Lancet Infectious Diseases·Daniel H KettUNKNOWN Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators
Feb 18, 2011·Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses·Diane J ChamberlainAndrew B Bersten
May 7, 2011·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Erin QuattromaniD Mark Courtney
May 17, 2011·Critical Care Medicine·Michael A PuskarichUNKNOWN Emergency Medicine Shock Research Network (EMSHOCKNET)
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
May 2, 2013·American Journal of Respiratory and Critical Care Medicine·Russell R MillerUNKNOWN Intermountain Healthcare Intensive Medicine Clinical Program
Mar 19, 2014·The New England Journal of Medicine·Donald M YealyDerek C Angus
Mar 29, 2014·Critical Care Medicine·Arthur R H van ZantenUNKNOWN Netherlands Patient Safety Agency Sepsis Expert Group
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Nov 15, 2014·Critical Care : the Official Journal of the Critical Care Forum·Mercedes Garcia-AlvarezRinaldo Bellomo
Mar 18, 2015·The New England Journal of Medicine·Paul R MounceyUNKNOWN ProMISe Trial Investigators
Jul 15, 2015·Intensive Care Medicine·Maurizio CecconiUNKNOWN ESICM Trial Group
Sep 9, 2015·Critical Care : the Official Journal of the Critical Care Forum·Peter M C Klein KlouwenbergTom van der Poll
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Mervyn SingerDerek C Angus
Jan 20, 2017·Intensive Care Medicine·Andrew RhodesR Phillip Dellinger
Jan 24, 2017·JAMA : the Journal of the American Medical Association·Michael D Howell, Andrew M Davis
Feb 6, 2017·Acta Anaesthesiologica Scandinavica·P B HjortrupA Perner
Mar 28, 2017·American Journal of Respiratory and Critical Care Medicine·Vincent X LiuGabriel J Escobar
May 23, 2017·The New England Journal of Medicine·Christopher W SeymourMitchell M Levy
May 26, 2017·Critical Care Medicine·Sarah A SterlingAlan E Jones
Jun 13, 2017·Journal of Intensive Care·Hiroshi Ueyama, Sawami Kiyonaka
Jun 13, 2017·JAMA Internal Medicine·Pranita D TammaSara E Cosgrove
Oct 4, 2017·JAMA : the Journal of the American Medical Association·Ben AndrewsGordon R Bernard
Nov 29, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN IDSA Sepsis Task Force
Dec 3, 2017·The Lancet. Respiratory Medicine·Nadia AlamUNKNOWN PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands
Jun 23, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Chanu RheeUNKNOWN CDC Prevention Epicenters Program
Jul 18, 2018·Critical Care Medicine·Chanu RheeUNKNOWN Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program
Sep 8, 2018·American Journal of Respiratory and Critical Care Medicine·Mitchell M LevyStanley Lemeshow
Dec 27, 2018·Critical Care Medicine·Ian J BarbashJeremy M Kahn
Jan 9, 2019·Chest·Paul E MarikUNKNOWN collaborating authors

❮ Previous
Next ❯

Citations

Jul 22, 2020·The Journal of Infectious Diseases·Edward J Septimus
Aug 4, 2021·Critical Care Medicine·R Phillip DellingerSean R Townsend

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Qatar Medical Journal
Ahmed Labib
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
K Kc HungC A Graham
© 2021 Meta ULC. All rights reserved